Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series-Reference-Cited by-同舟云学术

Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series

Published:2023-11 Issue:8 Volume:7 Page:102243
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Mendes-de-Almeida Daniela P.^ORCID,Mouta Nunes de Oliveira Patrícia^ORCID,Bertollo Gomes Porto Victor^ORCID,Saraiva Pedro Renata^ORCID,Takey Paulo Roberto Gomes^ORCID,Lignani Letícia Kegele^ORCID,Vitiello Teixeira Gabriellen^ORCID,Pereira Tainá dos Santos,Abreu Debora Lima^ORCID,Xavier Janaína Reis^ORCID,Castro Thalita da Matta de^ORCID,Melo de Amorim Filho Luiz^ORCID,Sousa Maia Maria de Lourdes de^ORCID,Bise Viegas Anna Paula,Júlio Liliam Cristiana,Pietrowski Bertuol Ana Paula,Fernandes Eder Gatti,Marques de Figueiredo Risoleide,Ferreira Rosane,Palm Cláudia Weingaertner,Burger Marion,Ferreira Diogenes Seraphim,Morgenstern Georgia Karina,Kamoi Tsukiyo Obu,Mattos de Carvalho Isis,Jenifer da Silva Araújo Cunha Juliana,Greffe Nadja,Nascimento Costa Nathalya Macedo,Genuino de Souza Thaina,Lima Frizzera Renata Loss,Furtado Barbara Emoingt,Nunes Gabriele Tantos,Garcez Tatiana,Filho Rubens Costa,Rodrigues Juliana Vassalo,Zago Luzia,Freire Claudio Renato

Publisher

Elsevier BV

Subject

Hematology

Reference21 articles.

1. The Advisory Committee on Immunization Practices’ Interim Recommendations for additional primary and booster doses of COVID-19 vaccines—United States, 2021;Mbaeyi;MMWR Morb Mortal Wkly Rep,2021

2. Omicron variant and booster COVID-19 vaccines;Burki;Lancet Respir Med,2022

3. Homologous and heterologous Covid-19 booster vaccinations;Atmar;N Engl J Med,2022

4. Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia

5. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial;Munro;Lancet,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia;Bleeding, Thrombosis and Vascular Biology;2024-06-20

2. 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19;Journal of Thrombosis and Haemostasis;2024-06

3. Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders;Journal of Clinical Medicine;2024-02-09

4. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia: A comprehensive review, release 1 (epidemiologic perspective);Life Cycle;2023-10-29